PFA
MRNA icon

Paradigm Financial Advisors’s Moderna MRNA Stock Holding History

Paradigm Financial Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-100
Closed -$10K – 223
2020
Q4 		$10K Buy
+100
New +$10.1K ﹤0.01% 168

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Paradigm Financial Advisors's MRNA Position: Q4 2021 in Review

Paradigm Financial Advisors reduced its Moderna (MRNA) stake by 7.3% in Q4 2021, selling an estimated $657K and leaving 28,692 shares worth $7.29M. The position accounts for 1.61% of the portfolio, ranked #17.

Paradigm Financial Advisors first reported a position in MRNA in Q4 2020 and has held it in 5 quarters since. The position peaked at $11.9M in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Paradigm Financial Advisors held 28,692 shares of Moderna worth $7.29M as of Q4 2021.
  • Paradigm Financial Advisors sold 2,248 Moderna shares in Q4 2021, an estimated $657K.
  • Moderna made up 1.61% of Paradigm Financial Advisors's portfolio in Q4 2021, its #17 holding.
  • Paradigm Financial Advisors first reported a position in Moderna in Q4 2020 and has held it in 5 quarters since.
  • Paradigm Financial Advisors's Moderna position peaked at $11.9M in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Paradigm Financial Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.